We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cephalon Settles Antitrust Claims With 48 States for $125M
Cephalon Settles Antitrust Claims With 48 States for $125M
Cephalon will pony up $125 million to settle multistate allegations that it paid drugmakers to delay generic competition of its sleep apnea drug Provigil.